Objective Measures of Physical Activity and Cardiometabolic and Endocrine Biomarkers. Issue 9 (September 2017)

• Record Type: Journal Article
• Authors: ALESSA, HALA B.; CHOMISTEK, ANDREA K.; HANKINSON, SUSAN E.; BARNETT, JUNAIDAH B.; ROOD, JENNIFER; MATTHEWS, CHARLES E.; RIMM, ERIC B.; WILLETT, WALTER C.; HU, FRANK B.; TOBIAS, DEIRDRE K.
• Is Part Of: Medicine and science in sports and exercise. Volume 49:Issue 9(2017)
• Publication Date: 2017-09
• Subjects: ACCELEROMETER -- DOUBLY LABELED WATER -- PHYSICAL ACTIVITY QUESTIONNAIRE -- CARDIOMETABOLIC RISK -- ENDOCRINE HEALTH -- EXERCISE; Sports medicine -- Periodicals; Exercise -- Physiological aspects -- Periodicals; Exercise -- Health aspects -- Periodicals; 612.044
• DOI: 10.1249/MSS.0000000000001287
• Languages: English
• ISSNs: 0195-9131

Abstract

ABSTRACT: Purpose: Although physical activity is an established risk factor for chronic disease prevention, the specific mechanisms underlying these relationships are poorly understood. We examined the associations between total activity counts and moderate-vigorous physical activity (MVPA) measured by accelerometer, and physical activity energy expenditure measured by doubly labeled water, with plasma levels of proinsulin, insulin, c-peptide, insulin growth factor binding protein-3, insulin growth factor-1, adiponectin, leptin, and leptin-sR. Methods: We conducted a cross-sectional analysis of 526 healthy US women in the Women's Lifestyle Validation Study, 2010 to 2012. We performed multiple linear regression models adjusting for potential lifestyle and health-related confounders to assess the associations between physical activity, measured in quartiles (Q) and biomarkers. Results: Participants in Q4 versus Q1 of total activity counts had lower proinsulin (−20%), c-peptide (−7%), insulin (−31%), and leptin (−46%) levels, and higher adiponectin (55%), leptin-sR (25%), and insulin growth factor-1 (9.6%) levels (all P trend ⩽ 0.05). Participants in Q4 versus Q1 of MVPA had lower proinsulin (−26%), c-peptide (−7%), insulin (−32%), and leptin (−40%) levels, and higher adiponectin (31%) and leptin-sR (22%) levels (all P trend ⩽ 0.05). Further adjustment for body mass index (BMI) attenuated these associations, but the associations with adipokines remained significant. Those in Q4 versus Q1 of physical activity energy expenditure had lower leptin (−21%) and higher leptin-sR (10%) levels (all P trend ⩽ 0.05), after additional adjustment for BMI. In the sensitivity analysis, the associations were similar but attenuated when physical activity was measured using the subjective physical activity questionnaire. Conclusions: Our data suggest that greater physical activity is modestly associated with favorable levels of cardiometabolic and endocrine biomarkers, where the strongest associations were found with accelerometer-measured physical activity. These associations may be only partially mediated through BMI, further supporting the role of physical activity in the reduction of cardiometabolic and endocrine disease risk, independent of adiposity. Abstract : Supplemental digital content is available in the text.